COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Procedures and Follow-up of Percutaneous Tracheostomy in Intensive Care Unit

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01792258
Recruitment Status : Unknown
Verified February 2016 by Paolo Pelosi, University of Genova.
Recruitment status was:  Recruiting
First Posted : February 15, 2013
Last Update Posted : February 3, 2016
Information provided by (Responsible Party):
Paolo Pelosi, University of Genova

Brief Summary:
Tracheostomy is worldwide performed in Intensive Care Unit (ICU). According to the current literature, indication for percutaneous tracheostomy (PDT) in ICU are: difficult prolonged weaning, prolonged mechanical ventilation, loss of airway reflex, copious secretions, upper airway obstruction. Many studies have focused on the comparison between different PDT techniques and complication. The aim of our study is to evaluate the procedural features, complications, ICU mortality, quality of life, post-discharge mortality of patients undergoing different PDT techniques performed in ICU.

Condition or disease Intervention/treatment
Acute Respiratory Failure Neurological Disease Heart Failure Procedure: Percutaneous tracheostomy

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Procedures, Complications and Follow-up of Percutaneous Tracheostomies in Intensive Care Unit
Study Start Date : June 2012
Estimated Primary Completion Date : February 2016
Estimated Study Completion Date : January 2017

Group/Cohort Intervention/treatment
critical ill patients
The investigator will enroll all the critical ill patients undergoing percutaneous tracheostomy performed in ICU
Procedure: Percutaneous tracheostomy
Percutaneous tracheostomies will be performed with the kit commercially available in the current clinical practice.

Primary Outcome Measures :
  1. Safety of percutaneous tracheostomy [ Time Frame: at the beginning and at the end of the procedure ]

Secondary Outcome Measures :
  1. Early complications [ Time Frame: in the first 24 hours from the end of the procedure ]
    Early complications are:multiple intubation attempts (more than 1), accidental extubation, paratracheal insertion, injuries to blood vessels in the neck, oesophageal injury, accidental decannulation, malposition of the tracheostomy tube, tracheal cuff puncture, multiple punctures (more than 1), surgical conversion and percutaneous tracheostomy failure, minor bleeding (compressible), major bleeding (incompressible), pneumothorax

  2. Late complications [ Time Frame: from the 2nd day ofter the procedure until the ICU discharge (expected average of 2 weeks) ]
    Late complications are: minor bleeding (compressible), major bleeding (incompressible) tracheostomy puncture site infection, subglottic stenosis, fracture of a tracheal cartilage, granuloma.

  3. Quality of life [ Time Frame: at 3, 6 and 12 months after tracheostomy ]
    The investigator will use the EURO-QOL

  4. Evaluation of organ function [ Time Frame: At 3, 6 , and 12 months after tracheostomy ]
    The investigator will perform a flexible fiberoptic laryngoscopy.

  5. Quality of voice [ Time Frame: At 3,6, 12 months after tracheostomy ]
    the investigator will use a KAY elemetrics analyzer.

  6. Mortality [ Time Frame: at 3, 6 and 12 months from tracheostomy ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 82 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Criticall ill patients requiring percutaneous tracheostomy in intensive care unit

Inclusion Criteria:

  • age >18
  • indication for tracheostomy

Exclusion Criteria:

  • infectious disease of neck

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01792258

Layout table for location contacts
Contact: Paolo Pelosi, professor +39 010 5553136

Layout table for location information
University of Genoa Recruiting
Genoa, Italy, 16132
Contact: Paolo Pelosi, professor    +39 010 555 3136   
Principal Investigator: Paolo Pelosi, professor         
Sub-Investigator: Maria Vargas, MD         
Sub-Investigator: Iole Brunetti, md         
Sponsors and Collaborators
University of Genova
Layout table for investigator information
Principal Investigator: Paolo Pelosi University of Genoa

Layout table for additonal information
Responsible Party: Paolo Pelosi, Professor, University of Genova Identifier: NCT01792258    
Other Study ID Numbers: 53/12
First Posted: February 15, 2013    Key Record Dates
Last Update Posted: February 3, 2016
Last Verified: February 2016
Keywords provided by Paolo Pelosi, University of Genova:
Percutaneous tracheostomy
Intensive Care Unit
Ineffective Airway Clearance
Weaning failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Respiratory Insufficiency
Nervous System Diseases
Respiration Disorders
Respiratory Tract Diseases